May 01, 2019
Lupus Research Alliance Kicks Off Lupus Awareness Month with "Breaking through for Lupus Research: 20 Years of Progress"
Apr 26, 2019
GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above
Apr 23, 2019
Mallinckrodt Lupus Phase 4 Clinical Study for Acthar® Gel (Repository Corticotropin Injection) Completes Enrollment in Difficult-to-Manage Population
Mar 19, 2019
Lupus Research Alliance Advocates Call on Congress to Fund More Lupus Scientific Exploration
Mar 01, 2019
Lupus Therapeutics Partners with Takeda on Phase 1 Trial
Jan 10, 2019
Lupus Research Alliance Announces Translational Research Grants to Speed Development of New Treatments
Dec 20, 2018
Two Outstanding Scientists Recognized for Transformative Lupus Research Projects
Dec 14, 2018
Lupus Research Alliance Applauds FDA's Fast Track Designation to Develop Baricitinib for Lupus
Dec 13, 2018
FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)
Nov 15, 2018
Opportunity Analysis on the Global Systemic Lupus Erythematosus Market (2018-2025) - Expected to Exhibit a CAGR of 7%
Nov 01, 2018
Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Management
Oct 23, 2018
Mallinckrodt and the Lupus Foundation of America Present Data from Survey of Over 1,500 Individuals with Self-Reported Lupus at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting
Oct 21, 2018
DxTerity Announces Presentations from Lupus and Multiple Sclerosis Studies at the 2018 ACR/ARHP Annual Meeting
Oct 17, 2018
OM1 Lupus Registry Reaches More Than 25,000 Patients Prospectively Followed With Deep Clinical And Lab Data
Oct 12, 2018
Lupus Research Alliance Awards Novel Research Grants to Six Trailblazing Studies
Oct 09, 2018
Global Systemic Lupus Erythematosus Market and Competitive Landscape 2014-2018 & 2023
Oct 05, 2018
Xencor Announces Topline Results from Phase 2 Study of XmAb®5871 in Systemic Lupus Erythematosus and Selection of Late-Breaking Abstract for Presentation at the 2018 ACR Annual Meeting
Sep 12, 2018
SLE Market Size Worth $3.08 Billion by 2025 | CAGR 7.0%: Grand View Research, Inc.
Aug 13, 2018
Provention Bio Reports Second Quarter 2018 Financial Results and Provides Business Update
Jul 25, 2018
Analysis of Over 1,000 Systemic Lupus Erythematosus Patients Reveals Real World Patient Populations are Not Representative of Clinical Trial Samples